guidelines·critical care, clinical trial, public health, internal medicine, family medicine·PMC10476406
Expert-approved best practice recommendations on the use of sedative drugs and intentional sedation in specialist palliative care (SedPall)
BMC Palliative Care · 15 authors, 6 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The study developed 66 best practice recommendations for using sedative drugs in specialist palliative care through a Delphi study and consensus conference with experts and public participants.
Full summary
804 CHARS
The process involved drafting recommendations based on previous guidance, normative and empirical analysis, and iterative feedback. A single-round Delphi study included 50 experts and patient/public involvement participants, followed by a consensus conference with 46 participants. The required agreement rate was set at ≥80%. In total, 66 recommendations were approved, covering topics such as indications, decision-making, information and consent, medication, monitoring, and support for relatives and teams. The recommendations address the clinical, ethical, and legal challenges of end-of-life sedation, including the distinction between therapeutic drug side effects and intentional sedation. Limitations include the need for future research to evaluate implementation feasibility and effectiveness.
